Dr. Colin Tsukio Watanabe, MD

Dr. Watanabe practices at Southern California Permanente Medical Group in Los Angeles, California.

Dr. Watanabe's NPI, 1053482968, was assigned on November 13, 2006. Dr. Watanabe graduated from UCSF School of Medicine in 1999. Dr. Watanabe holds California license A78981.

Dr. Watanabe's primary practice is Southern California Permanente Medical Group, at 4760 W Sunset Blvd, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 783-4011.

Dr. Watanabe's primary practice is Southern California Permanente Medical Group in Los Angeles, California. Dr. Watanabe is also affiliated with Kaiser Permanente Los Angeles Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Watanabe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watanabe practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Watanabe's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Watanabe is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Watanabe is licensed in California.

Dmand AI lists sleep apnea and tobacco use among the conditions Dr. Watanabe treats.

CMS data shows 21 Medicare services from Dr. Watanabe across 1 procedure code in 2024, for 41 Medicare patients. Medicare paid $1,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Watanabe in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Watanabe's median patient age at 71, with 51% women.

In 2024, Dr. Watanabe wrote 4,015 Medicare Part D claims for 511 patients. 85% of them were for generic drugs. CMS names the drug for 3,888 of them, across 36 drugs with 11 or more claims each, at $1,547,074 in total drug cost. In 2023, CMS named 3,737 claims across 35 drugs.

Dr. Watanabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Watanabe, published from 2017 to 2019. Dr. Watanabe's most frequent co-author is James C. Lee, MD.

CMS Open Payments shows 43 general payments to Dr. Watanabe from 4 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 75% of the total. Abbott Laboratories paid the most, $2,940.

Dmand AI lists 3 awards for Dr. Watanabe, most recently ACC Fellow in 2011.

Dr. Watanabe graduated from UCSF School of Medicine in 1999. Dr. Watanabe is a member of ACC.

Dr. Watanabe is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.